Atombeam Technologies
- 05/02/2025
- Unknown
- $20,000,000
Atombeam has the potential to revolutionize data management through its Data-as-Codewords Neurpac technology, altering how data is encoded, used, transferred, managed, stored and secured. Atombeam increases available bandwidth an average of 4x, improves access to stored data by making it searchable while encoded, and enhances security with ultralight software, all in a single computing step. Atombeam’s Neurpac is uniquely capable of operating on the smallest machine-generated or Internet of Things data, which is not possible with compression.
- Industry Software Development
- Website https://www.atombeamtech.com/
- LinkedIn https://www.linkedin.com/company/atombeam/
Related People
Charles YeomansFounder
Leading Atombeam Technologies as CEO & Founder, my focus has been on innovating data streaming solutions for the growing IoT sector. Atombeam is a software company led by a highly experienced, senior team with 40 FTE and 71 issued/allowed and 101 pending patents. Atombeam’s three products represent a potential revolution in data efficiency, security and analytics.
- Neurpac has the potential to drive massive efficiency and security improvements for almost any system, expanding effective bandwidth by 4x, while adding encryption and allowing full searchability and random access to encoded data;
- Neurcom, under an Air Force contract, is an AI enhanced compression that has the ability to double the capabilities of standard techniques;
-The Lightweight Codeword Model, or LCM, is projected to utilize the informationally dense data generated by Neurpac and Neurcom to save at least 25% by driving efficiency in training and power use for generative AI.
My tenure as Chairman at Trigemina, Inc. was marked by successful capital raising efforts, accumulating approximately $20 million, and advancing biotechnological research. The team’s dedication to developing pain management solutions via intranasal administration has been a significant part of my professional journey. Our collective efforts in both biotechnology and technology sectors underscore a commitment to innovation and the pursuit of industry-leading advancements.
I also have deep experience as a Wall Street investment banker, and prior to business school was an intelligence officer with the U.S. Navy.